Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off.

In the realm of molecular biology, histone modification plays a pivotal role in shaping the epigenetic landscape of chromatin.